Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters








Database
Language
Publication year range
1.
PLoS One ; 8(5): e65045, 2013.
Article in English | MEDLINE | ID: mdl-23717688

ABSTRACT

The nucleocapsid (N) phosphoprotein of the severe acute respiratory syndrome coronavirus (SARS-CoV) packages the viral genome into a helical ribonucleocapsid and plays a fundamental role during viral self-assembly. The N protein consists of two structural domains interspersed between intrinsically disordered regions and dimerizes through the C-terminal structural domain (CTD). A key activity of the protein is the ability to oligomerize during capsid formation by utilizing the dimer as a building block, but the structural and mechanistic bases of this activity are not well understood. By disulfide trapping technique we measured the amount of transient oligomers of N protein mutants with strategically located cysteine residues and showed that CTD acts as a primary transient oligomerization domain in solution. The data is consistent with the helical oligomer packing model of N protein observed in crystal. A systematic study of the oligomerization behavior revealed that altering the intermolecular electrostatic repulsion through changes in solution salt concentration or phosphorylation-mimicking mutations affects oligomerization propensity. We propose a biophysical mechanism where electrostatic repulsion acts as a switch to regulate N protein oligomerization.


Subject(s)
Nucleocapsid Proteins/chemistry , Severe acute respiratory syndrome-related coronavirus , Amino Acid Substitution , Calcium Carbonate , Citrates , Cystine/chemistry , Drug Combinations , Magnesium Oxide , Models, Molecular , Mutagenesis, Site-Directed , Nucleocapsid Proteins/genetics , Phosphorylation , Protein Interaction Domains and Motifs , Protein Multimerization , Protein Processing, Post-Translational , Virus Assembly
2.
J Bacteriol ; 194(23): 6518-26, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23024345

ABSTRACT

Feo is a transport system commonly used by bacteria to acquire environmental Fe(2+). It consists of three proteins: FeoA, FeoB, and FeoC. FeoB is a large protein with a cytosolic N-terminal domain (NFeoB) that contains a regulatory G protein domain and a helical S domain. The C-terminal region of FeoB is a transmembrane domain that likely acts as the Fe(2+) permease. NFeoB has been shown to form a trimer pore that may function as an Fe(2+) gate. FeoC is a small winged-helix protein that possesses four conserved cysteine residues with a consensus sequence that likely provides binding sites for the [Fe-S] cluster. Therefore, FeoC is presumed to be an [Fe-S] cluster-dependent regulator that directly controls transcription of the feo operon. Despite the apparent significance of the Feo system, however, the function of FeoC has not been experimentally demonstrated. Here, we show that Klebsiella pneumoniae FeoC (KpFeoC) forms a tight complex with the intracellular N-terminal domain of FeoB (KpNFeoB). The crystal structure of the complex reveals that KpFeoC binds to KpNFeoB between the switch II region of the G protein domain and the effector S domain and that the long KpFeoC W1 loop lies above the KpNFeoB nucleotide-binding site. These interactions suggest that KpFeoC modulates the guanine nucleotide-mediated signal transduction process. Moreover, we showed that binding of KpFeoC disrupts pore formation by interfering with KpNFeoB trimerization. These results provide strong evidence suggesting that KpFeoC plays a crucial role in regulating Fe(2+) transport in Klebsiella pneumonia in addition to the presumed gene regulator role.


Subject(s)
Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Iron/metabolism , Klebsiella pneumoniae/chemistry , Klebsiella pneumoniae/metabolism , Membrane Transport Proteins/chemistry , Membrane Transport Proteins/metabolism , Crystallography, X-Ray , Models, Molecular , Protein Binding , Protein Multimerization , Protein Structure, Quaternary
4.
Protein Sci ; 18(11): 2209-18, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19691129

ABSTRACT

Human coronavirus OC43 (HCoV-OC43) is one of the causes of the "common cold" in human during seasons of cold weather. The primary function of the HCoV-OC43 nucleocapsid protein (N protein) is to recognize viral genomic RNA, which leads to ribonucleocapsid formation. Here, we characterized the stability and identified the functional regions of the recombinant HCoV-OC43 N protein. Circular dichroism and fluorescence measurements revealed that the HCoV-OC43 N protein is more highly ordered and stabler than the SARS-CoV N protein previously studied. Surface plasmon resonance (SPR) experiments showed that the affinity of HCoV-OC43 N protein for RNA was approximately fivefold higher than that of N protein for DNA. Moreover, we found that the HCoV-OC43 N protein contains three RNA-binding regions in its N-terminal region (residues 1-173) and central-linker region (residues 174-232 and 233-300). The binding affinities of the truncated N proteins and RNA follow the order: residues 1-173-residues 233-300 > residues 174-232. SPR experiments demonstrated that the C-terminal region (residues 301-448) of HCoV-OC43 N protein lacks RNA-binding activity, while crosslinking and gel filtration analyses revealed that the C-terminal region is mainly involved in the oligomerization of the HCoV-OC43 N protein. This study may benefit the understanding of the mechanism of HCoV-OC43 nucleocapsid formation.


Subject(s)
Coronavirus OC43, Human/chemistry , Nucleocapsid Proteins/metabolism , RNA-Binding Proteins/metabolism , Recombinant Proteins/metabolism , Binding Sites , Circular Dichroism , Coronavirus Nucleocapsid Proteins , Glutaral/chemistry , Humans , Nucleic Acids/metabolism , Nucleocapsid Proteins/chemistry , Protein Multimerization , Protein Stability , RNA-Binding Proteins/chemistry , Recombinant Proteins/chemistry , Spectrometry, Fluorescence , Urea/chemistry
5.
Biophys J ; 96(5): 1892-901, 2009 Mar 04.
Article in English | MEDLINE | ID: mdl-19254548

ABSTRACT

Differential scanning calorimetry, circular dichroism spectroscopy, nuclear magnetic resonance spectroscopy, and numerical simulations were used to study the thermostability of the N-terminal RNA-binding domain (RBD) of the SARS-CoV nucleocapsid protein. The transition temperature of the RBD in a mixing buffer, composed of glycine, sodium acetate, and sodium phosphate with 100 mM sodium chloride, at pH 6.8, determined by differential scanning calorimetry and circular dichroism, is 48.74 degrees C. Experimental results showed that the thermal-induced unfolding-folding transition of the RBD follows a two-state model with a reversibility >90%. Using a simple Go-like model and Langevin dynamics we have shown that, in agreement with our experiments, the folding of the RBD is two-state. Theoretical estimates of thermodynamic quantities are in reasonable agreement with the experiments. Folding and thermal unfolding pathways of the RBD also were experimentally and numerically studied in detail. It was shown that the strand beta(1) from the N-terminal folds last and unfolds first, while the remaining beta-strands fold/unfold cooperatively.


Subject(s)
Nucleocapsid Proteins/chemistry , Severe acute respiratory syndrome-related coronavirus/chemistry , Algorithms , Calorimetry, Differential Scanning , Circular Dichroism , Computer Simulation , Coronavirus Nucleocapsid Proteins , Models, Chemical , Models, Molecular , Nuclear Magnetic Resonance, Biomolecular , Nucleocapsid Proteins/metabolism , Protein Folding , Protein Stability , Protein Structure, Tertiary , RNA/metabolism , Temperature , Thermodynamics , Transition Temperature
6.
J Virol ; 83(5): 2255-64, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19052082

ABSTRACT

The nucleocapsid protein (N) of the severe acute respiratory syndrome coronavirus (SARS-CoV) packages the viral genomic RNA and is crucial for viability. However, the RNA-binding mechanism is poorly understood. We have shown previously that the N protein contains two structural domains--the N-terminal domain (NTD; residues 45 to 181) and the C-terminal dimerization domain (CTD; residues 248 to 365)--flanked by long stretches of disordered regions accounting for almost half of the entire sequence. Small-angle X-ray scattering data show that the protein is in an extended conformation and that the two structural domains of the SARS-CoV N protein are far apart. Both the NTD and the CTD have been shown to bind RNA. Here we show that all disordered regions are also capable of binding to RNA. Constructs containing multiple RNA-binding regions showed Hill coefficients greater than 1, suggesting that the N protein binds to RNA cooperatively. The effect can be explained by the "coupled-allostery" model, devised to explain the allosteric effect in a multidomain regulatory system. Although the N proteins of different coronaviruses share very low sequence homology, the physicochemical features described above may be conserved across different groups of Coronaviridae. The current results underscore the important roles of multisite nucleic acid binding and intrinsic disorder in N protein function and RNP packaging.


Subject(s)
Nucleocapsid Proteins/chemistry , Ribonucleoproteins/chemistry , Severe acute respiratory syndrome-related coronavirus/chemistry , Amino Acid Sequence , Binding Sites , Coronavirus Nucleocapsid Proteins , Electrophoretic Mobility Shift Assay , Magnetic Resonance Spectroscopy , Molecular Sequence Data , Nucleocapsid Proteins/genetics , Protein Binding , Protein Structure, Secondary , RNA, Viral/metabolism , Ribonucleoproteins/genetics , Severe acute respiratory syndrome-related coronavirus/genetics , Scattering, Small Angle , Sequence Alignment , X-Ray Diffraction
7.
J Mol Biol ; 380(4): 608-22, 2008 Jul 18.
Article in English | MEDLINE | ID: mdl-18561946

ABSTRACT

The C-terminal domain (CTD) of the severe acute respiratory syndrome coronavirus (SARS-CoV) nucleocapsid protein (NP) contains a potential RNA-binding region in its N-terminal portion and also serves as a dimerization domain by forming a homodimer with a molecular mass of 28 kDa. So far, the structure determination of the SARS-CoV NP CTD in solution has been impeded by the poor quality of NMR spectra, especially for aromatic resonances. We have recently developed the stereo-array isotope labeling (SAIL) method to overcome the size problem of NMR structure determination by utilizing a protein exclusively composed of stereo- and regio-specifically isotope-labeled amino acids. Here, we employed the SAIL method to determine the high-quality solution structure of the SARS-CoV NP CTD by NMR. The SAIL protein yielded less crowded and better resolved spectra than uniform (13)C and (15)N labeling, and enabled the homodimeric solution structure of this protein to be determined. The NMR structure is almost identical with the previously solved crystal structure, except for a disordered putative RNA-binding domain at the N-terminus. Studies of the chemical shift perturbations caused by the binding of single-stranded DNA and mutational analyses have identified the disordered region at the N-termini as the prime site for nucleic acid binding. In addition, residues in the beta-sheet region also showed significant perturbations. Mapping of the locations of these residues onto the helical model observed in the crystal revealed that these two regions are parts of the interior lining of the positively charged helical groove, supporting the hypothesis that the helical oligomer may form in solution.


Subject(s)
Nuclear Magnetic Resonance, Biomolecular/methods , Nucleocapsid Proteins/chemistry , Protein Structure, Tertiary , Severe acute respiratory syndrome-related coronavirus/chemistry , Amino Acid Sequence , Binding Sites , Coronavirus Nucleocapsid Proteins , Crystallography, X-Ray , Dimerization , Humans , Models, Molecular , Molecular Sequence Data , Molecular Structure , Mutagenesis, Site-Directed , Nucleocapsid Proteins/genetics , Protein Structure, Quaternary , Ribonucleoproteins/chemistry , Ribonucleoproteins/metabolism , Severe Acute Respiratory Syndrome/virology
SELECTION OF CITATIONS
SEARCH DETAIL